AU2001278416A1 - Mannan-binding lectin (mbl) treatment of infections in individuals treated with tnf-alphainhibitors - Google Patents

Mannan-binding lectin (mbl) treatment of infections in individuals treated with tnf-alphainhibitors

Info

Publication number
AU2001278416A1
AU2001278416A1 AU2001278416A AU7841601A AU2001278416A1 AU 2001278416 A1 AU2001278416 A1 AU 2001278416A1 AU 2001278416 A AU2001278416 A AU 2001278416A AU 7841601 A AU7841601 A AU 7841601A AU 2001278416 A1 AU2001278416 A1 AU 2001278416A1
Authority
AU
Australia
Prior art keywords
alphainhibitors
mbl
mannan
tnf
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278416A
Other languages
English (en)
Inventor
Per Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NatImmune AS
Original Assignee
NatImmune AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NatImmune AS filed Critical NatImmune AS
Publication of AU2001278416A1 publication Critical patent/AU2001278416A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001278416A 2000-07-13 2001-07-13 Mannan-binding lectin (mbl) treatment of infections in individuals treated with tnf-alphainhibitors Abandoned AU2001278416A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001088 2000-07-13
DKPA200001088 2000-07-13
PCT/DK2001/000491 WO2002005833A1 (fr) 2000-07-13 2001-07-13 Traitement a la lectine de liaison au mannane d'infections chez les personnes traitees avec des inhibiteurs de tnf-$g(a)

Publications (1)

Publication Number Publication Date
AU2001278416A1 true AU2001278416A1 (en) 2002-01-30

Family

ID=8159616

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278416A Abandoned AU2001278416A1 (en) 2000-07-13 2001-07-13 Mannan-binding lectin (mbl) treatment of infections in individuals treated with tnf-alphainhibitors

Country Status (4)

Country Link
US (1) US7387993B2 (fr)
EP (1) EP1303288A1 (fr)
AU (1) AU2001278416A1 (fr)
WO (1) WO2002005833A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1186299A1 (fr) * 2000-09-12 2002-03-13 Universitair Medisch Centrum Utrecht Diagnostic, prévention et/ou traitement d' athérosclérose, infections et perturbations du système immunitaire
US7211396B2 (en) 2002-04-18 2007-05-01 Antibodyshop A/S Antibody pairs and kits for immunochemical determination of mannan-binding lectin
CA2472438A1 (fr) * 2002-06-28 2004-01-08 Fuso Pharmaceutical Industries, Ltd. Agent anti-hiv
GB0222014D0 (en) * 2002-09-23 2002-10-30 Leuven K U Res & Dev Mannan-binding lectin
WO2004065626A2 (fr) * 2003-01-17 2004-08-05 Rigshospitalet Procede permettant de pronostiquer une sepsie
US20050191685A1 (en) 2004-02-24 2005-09-01 Innogenetics N.V. Method for determining the risk of developing a neurological disease
US20090247454A1 (en) * 2004-09-29 2009-10-01 Mellitus, S.L. Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease
EP1833502B1 (fr) * 2004-12-23 2011-03-02 Council of Scientific and Industrial Research Composition pharmaceutique pour le traitement de l'aspergillose pulmonaire invasive
WO2008019322A2 (fr) * 2006-08-04 2008-02-14 Enzon Pharmaceuticals, Inc. Méthodes pour inhiber et réduire une croissance tumorale qui utilise la lectine humaine liant le mannose

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG89295A1 (en) * 1991-03-15 2002-06-18 Amgen Inc Pegylation of polypeptides
US6224870B1 (en) * 1997-01-24 2001-05-01 Genitrix, Ltd. Vaccine compositions and methods of modulating immune responses
WO1999064453A1 (fr) * 1998-06-10 1999-12-16 Statens Serum Institut Technique de purification aux fins de la production d'une lectine se fixant a la mannane (mbl) et d'un produit medical mbl
WO2000070043A1 (fr) * 1999-05-14 2000-11-23 Steffen Thiel Lectine humaine de recombinaison se fixant a la mannane

Also Published As

Publication number Publication date
EP1303288A1 (fr) 2003-04-23
US20040029785A1 (en) 2004-02-12
US7387993B2 (en) 2008-06-17
WO2002005833A1 (fr) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
GB2395662B (en) Emollient exfoliating composition and its use in cleansing and conditioning skin
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
AU2001278416A1 (en) Mannan-binding lectin (mbl) treatment of infections in individuals treated with tnf-alphainhibitors
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
HK1067298A1 (zh) 應用於治療皮膚和/或粘膜損傷的體表應用的藥物組合物；組合物在治療皮膚和/或粘膜損傷中的用途和化合物在治療皮膚和/或粘膜損傷中的用途
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
AU2002340251A1 (en) Use of mx gtpases in the prognosis and treatment of cancer
GB2398777B (en) Improvements in or relating to water and wastewater treatment
AU2002228660A1 (en) Use of amidoamines to treat or prevent acanthamoeba and fungal infections
AU2001294786A1 (en) Use of il-8 protein modulators in the treatment of viral infections
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2001211673A1 (en) Use of melanins in compositions for removing make-up from and/or cleansing the skin and mucous membranes
AU2003238175A1 (en) Treatment of serious infections and septic shock
AUPQ691200A0 (en) Improvements in boiling and/or chilling water units
AU2001231009A1 (en) Use of pro-apoptotic factors in treatment of atherosclerosis
GB0107837D0 (en) Biological materials and methods for use in the prevention or treatment of infections:II
GB0107840D0 (en) Biological materials and methods for use in the prevention or treatment of infections:I
AU2001260457A1 (en) Biological materials and methods for use in the prevention or treatment of infections
HUP0600114A2 (en) Benzofuran derivatives and their use in the treatment of microbal infections
NO20004130D0 (no) Behandling av mikro-organismer og biobelegg i reservoarer